BioSpace News Archive

Business

Novartis Nabs Merck Veteran to Helm BioMedical Institutes

Fiona H. Marshall has been tapped as Novartis Institutes for BioMedical Research president after Jay Bradner’s exit, while Tim Demuth will succeed Malte Peters for MorphoSys.

September 1, 2022
·
2 min read
·
Alex Keown
Policy

AstraZeneca Wins Injunction, Blocking Former Exec from Joining GSK

A High Court judge in London granted AstraZeneca an injunction, temporarily blocking a former executive from joining rival pharma GSK.

September 1, 2022
·
2 min read
·
Tristan Manalac
Business

Provention Nabs $125M in Preparation for Potential Diabetes Drug Launch

Provention Bio secured a $125 million loan from Hercules Capital that will support operations and the potential launch of the company’s type 1 diabetes treatment, teplizumab.

September 1, 2022
·
2 min read
·
Alex Keown
Policy

Biopharma Needs to Protect more than Crown Jewel IP to Stay Competitive

The problem of intellectual property theft is greater than most biopharma executives realize, but the real issue is that companies are protecting only a fraction of their IP.

September 1, 2022
·
6 min read
·
Gail Dutton
Drug Development

AnaptysBio Pins Hopes on Pustular Psoriasis after Failed HS Trial

Shares of AnaptysBio are down more than 16% after imsidolimab failed to meet the endpoint in a Phase II trial assessing its efficacy in hidradenitis suppurativa.

September 1, 2022
·
2 min read
·
Alex Keown
Drug Development

Sanofi Wins FDA Approval for First ASMD Drug

Sanofi announced FDA approval of Xenpozyme for adult and pediatric patients with the rare genetic disease acid sphingomyelinase deficiency, often referred to as Niemann-Pick disease.

September 1, 2022
·
3 min read
·
Tristan Manalac
Deals

Novo Nordisk Shells Out $1.1B for Forma, Sickle Cell Drug

Novo Nordisk has entered into an agreement to acquire Forma Therapeutics for $1.1 billion. Forma’s lead development candidate, etavopivat, is being developed for sickle cell disease.

September 1, 2022
·
2 min read
·
Mark Terry
Business

Movers & Shakers: Galera, Verily, Avid and More Tap New Execs

Biopharma and life sciences companies, such as Seraxis, Verily and Vaxart, tap new members to bolster their leadership teams in roles like CMO, CTO, CCO, and more.

September 1, 2022
·
4 min read
·
Alex Keown
Research Roundup: TPOXX Found Effective Against Monkeypox and More

As the monkeypox outbreak continues in the U.S. and abroad, researchers and health officials race to test drugs against the disease. For that and more research stories, continue reading.

September 1, 2022
·
5 min read
·
Mark Terry
FDA

FDA Greenlights New COVID-19 Boosters Despite Lack of In-Human Data

On Wednesday, the FDA authorized new Omicron-specific booster shots for Pfizer-BioNTech and Moderna’s COVID-19 vaccines despite a lack of human data.

September 1, 2022
·
3 min read
·
Mark Terry